In vivo kinetics of micronuclei induction by bifunctional alkylating antineoplastics

Mutagenesis

Volumn 19, Issue 3, 2004, Pages 207-213

  Morales Ramírez, Pedro ^a   Vallarino Kelly, Teresita ^a   Cruz Vallejo, Virginia L ^a   López Iturbe, Rosario ^a   Alvaro Delgadillo, Horacio ^a  

^a INSTITUTO NACIONAL DE INVESTIGACIONES NUCLEARES   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; BUSULFAN; CARMUSTINE; CISPLATIN; ETHYLNITROSOUREA; MERCAPTOPURINE; METHYLNITROSOUREA; MITOMYCIN C;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; CELL DAMAGE; CELL DIVISION; CELL KINETICS; CONTROLLED STUDY; CROSS LINKING; DRUG CYTOTOXICITY; DRUG EXPOSURE; ERYTHROCYTE; EXCISION REPAIR; FREQUENCY ANALYSIS; GENOTOXICITY; IN VIVO STUDY; MICRONUCLEUS; MISMATCH REPAIR; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; ERYTHROCYTES, ABNORMAL; GENETIC TECHNIQUES; KINETICS; MICE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; TIME FACTORS;

EID: 2942523682     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/geh018     Document Type: Article

References (45)

1. Aida,T. and Bodell,W.J. (1987) Cellular resistente to chloroethylnitrosoureas, nitrogen mustard and cis-diamminedichloroplatinum(II) in human glial-derived cell lines. Cancer Res., 47, 1361-1366.
2. Allan,J.M., Engelward,B.P., Dreslin,A.J., Wyatt,M.D., Tomasz,M. and Samson,L.D. (1998) Mammalian 3-methyladenine DNA glycosylase protects against the toxicity and clastogenicity of certain chemotherapeutic DNA cross-linking agents. Cancer Res., 58, 3965-3973.
3. Armstrong,M.J. and Galloway,S.M. (1997) Mismatch repair provokes chromosome aberrations in hamster cells treated with methylating agents or 6-thioguanine, but not with ethylating agents. Mutat. Res., 373, 167-178.
4. Bedford,P. and Eisenbrand,G. (1984) DNA damage and repair in the bone marrow of rats treated with four chloroethylnitrosoureas. Cancer Res., 44, 514-518.
5. Bedford,P. and Fox,B.W. (1982) Repair of DNA interstrand crosslinks after busulphan. A possible mode of resistance. Cancer Chemother. Pharmacol., 8, 3-7.
6. Beranek,D.T. (1990) Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat. Res., 231, 11-30.
7. Bodell,W.J., Aida,T. and Berger,M.S. (1985a) Repair of O6-(2-chloroethyl)guanine mediates the biological effects of chloroethyl-nitrosoureas. Environ. Health Perspect., 62, 119-126
8. Bodell,W.J., Gerosa,M., Aida,T, Berger,M.S. and Rosemblum,M.L. (1985b) Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas. Cancer Res., 45, 3460-3464.
9. Dix,S.P., Wingard,J.R., Mullins,R.E. et al. (1996) Association of busulfan area under the curve with veno-occlusive disease following BMT. Bone Marrow Transplant, 17, 225-230.
10. Donoho,G., Brenneman,M.A., Cui,T.X., Donoviel,D., Vogel,H., Goodwin,E.H., Chen,D.J. and Hasty,P. (2003) Deletion of Brca2 exon 27 causes hypersesitivity to DNA crosslinks, chromosomal instability and reduced life span in mice. Genes Chromosomes Cancer, 36, 317-331
11. Engelward,B.P., Dreslin,A., Christensen,J., Huszard,D., Kurahara,C. and Samson,L. (1996) Repair deficient 3 methyladenine DNA glycosylase homozygous mutant mouse cells have increased sensitivity to alkylation-induced chromosome damage and cell killing. EMBO J., 15, 945-952.
12. Erlichman,C. (1988) The pharmacology of anticancer drugs. In Tannock,I.F. and Hill,R.P. (eds), The Basic Science of Oncology. Pergamon Press, New York, NY, pp. 292-307.
13. Essers,J., van Steeg,H., de Wit,J., Swagemakers,S.M.A., Vermeij,M., Hoeijmakers,J.H.J. and Kanaar,R. (2000) Homologous and non-homologous recombination affect DNA damage repair in mice. EMBO J., 19, 1703-1710.
14. Fink,D., Aebi,S. and Howell,S.B. (1998a) The role of DNA mismatch repair in drug resistance. Clin. Cancer Res., 4, 1-6.
15. Fink,D., Nebel,S., Norris,P.S., Baergen,R.N., Wilczynski,S.P., Costa,M.J., Haas,M., Cannistra,S.A. and Howell,S.B. (1998b) Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatin. Int. J. Cancer, 77, 741-746.
16. Fuertesa,M.A., Castillab,J., Alonsoa,C. and Perez,J.M. (2003) Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. Curr. Med. Chem., 10, 257-266.
17. Glassner,B.J., Weeda,G., Allan,J.M. et al. (1999) DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents. Mutagenesis, 14, 339-347.
18. Gustafson,D.L., Trotter,B.K., Snead,D. and Waldren,C.A. (1997) Expression of human O6-methyl guanine methyl transferase (MGMT) in post replication repair (PRR) deficient CHO-UV-1 cells: compensation for hypersensitivity to methylating and ethylating agents but not to mitomycin C. Somat. Cell Mol. Genet., 23, 9-17.
19. Hincks,J.R., Adlakha,A., Cook,C.A., Johnson,C.S., Furmanski,P. and Gibson,N.W. (1990) In vitro studies on the mechanism of action of hepsulfam in chronic myelogenous leukemia patients. Cancer Res., 50, 7559-7563.
20. Jones,J.C., Zhen,W., Reed,E., Parker,R.J., Sancar,A. and Bohr,V.A. (1991) Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand crosslinks in Chinese hamster ovary cells. J. Biol. Chem., 266, 7101-7107.
21. Khon,K.W. (1977) Interstrand crosslinking of DNA by 1,3-bis(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-nitrosoureas. Cancer Res., 37, 1450-1454.
22. Kokkinakis,D.M., Moschel,R.C., Pegg,A.E. and Schold,S.C. (1999) Eradicaction of human medulloblastoma tumor xenografts with a combination of O6-benzyl-2′-deoxyguanosine and 1,3-bis(2-chloroethyl)-1-nitrosourea. Clin. Cancer Res., 5, 3676-3681.
23. Lindor,N.M., Jalal,S.M., VanDeWalker,T.J., Cunningham,J.M., Dahl,R.J. and Thibodeau,S.N. (1998) Search for chromosome instability in lymphocytes with germ-line mutations in DNA mismatch repair genes. Cancer Genet. Cytogenet., 104, 48-51.
24. Maze,R., Carney,J.P., Kelley,M.R., Glassner,B.J. and Williams,D.A. (1996) Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent. Proc. Natl Acad. Sci. USA, 93, 206-210.
25. Merk,O. and Speit,G. (1998) Signficance of formaldehyde-induced DNA-protein crosslinks for mutagenesis. Environ. Mol. Mutagen., 32, 260-268.
26. Millard,J.T., Weidner,M.F., Kirchner,J.J., Ribeiro,S. and Hopkins,P.B. (1991) Sequence preferences of DNA interstrand crosslinking agents: quantitation of interstrand crosslink locations in DNA duplex fragments containing multiple crosslinkable sites. Nucleic Acids Res., 19, 1885-1891.
27. Mitra,S. and Kaina,B. (1993) Regulation of repair of alkylation damage in mammalian genomes. Prog. Nucleic Acid Res. Mol. Biol., 44, 109-142.
28. Morales-Ramírez,P. and Vallarino-Kelly,T. (1998) Pharmacokinetic parameters determined from the clastogenic activity of ethylnitrosourea (ENU) and dimethylnitrosamine (DMN) in mice in vivo. Mutat. Res., 412, 315-322.
29. Morales-Ramírez,P. and Vallarino-Kelly,T. (1999) Relationship between the kinetics of micronuclei induction and the mechanism of chromosome break formation by methylnitrosourea in mice in vivo. Mutat. Res., 427, 31-38.
30. Morales-Ramírez,P., Vallarino-Kelly,T., Anguiano-Orozco,G. and Rodríguez-Reyes,R. (1997) Pharmacokinetic parameters of genotoxic activity inferred by the comparison of the kinetics of MN-PCE induced by chemical agents and ionizing radiation. Mutat. Res., 391, 127-134.
31. Moynahan,M.E., Cui,T.Y. and Jasón,M. (2001) Homology-directed DNA repair, mitomycin-C resistance and chromosome stability is restored with correction of a Brca1 mutation. Cancer Res., 61, 4842-4850.
32. Ochs,K., Sobol,R.W., Wilson,S.H. and Kaina,B. (1999) Cells deficient in DNA polymerase beta are hypersensitive to alkylating agent-induced apoptosis and chromosomal breakage. Cancer Res., 59, 1544-1551.
33. Pacheco,D.Y., Stratton,N.K. and Gibson,N.W. (1989) Comparison of the mechanism of action of busulfan with hepsulfam, a new antileukemic agent, in the L1210 cell line. Cancer Res., 49, 5108-5110.
34. Pacheco,D.Y., Cook,C., Hincks,J.R. and Gibson,N.W. (1990) Mechanisms of toxicity of hepsulfam in human tumor cell lines. Cancer Res., 50, 7555-7558.
35. Pluth,J.M., Fried,L.M. and Kirchgessner,C.U. (2001) Severe combined immunodeficient cells expressing mutant hRAD54 exhibit a marked DNA double-strand break repair and error-prone chromosome repair defect. Cancer Res., 61, 2649-2655.
36. Rodríguez-Reyes,R. and Morales-Ramírez,P. (2003) Sister chromatid exchange induction and the course of DNA duplication, two mechanisms of sister chromatid exchange induction by ENU and the role of BrdU. Mutagenesis, 18, 65-72.
37. Schmid,W. (1975) The micronucleus. Mutat. Res., 31, 9-15.
38. Schuler,U.S., Ehrsam,M., Schneider,A., Schmidt,H., Deeg,J. and Ehninger,G. (1998) Pharmacokinetics of intravenous busulfan and evaluation of the bioavailability of the oral formulation in conditioning for haematopoietic stem cell transplantation. Bone Marrow Transplant, 22, 241-244.
39. Schwartz,J.L., Turkula,T., Sagher,D. and Strauss,B. (1989) The relationship between O6-alkylguanine alkyltransferase activity and sensitivity to alkylation-induced sister chromatid exchanges in human lymphoblastoid cell lines. Carcinogenesis, 10, 681-685.
40. Sibghat-Ullah, Hussain,I., Carlton,W. and Sancar,A. (1989) Human nucleotide excisión repair in vitro: repair of pyrimidine dimers, psoralen and cisplatin adducts by HeLa cell free extract. Nucleic Acids Res., 17, 4471-4484.
41. Tomasz,M. (1995) Mitomycin C: small, fast and deadly (but very selective). Chem. Biol., 2, 575-579.
42. Vallarino-Kelly,T. and Morales-Ramírez,P. (2001) Kinetics of micronucleus induction and cytotoxic activity of colchicine in murine erythroblast in vivo. Mutat. Res., 495, 51-59.
43. Vernole,P., Pepponi,R. and D'Atri,S. (2003) Role of mismatch repair in the induction of chromosomal aberrations and sister chromatid exchanges in cells treated with different chemotherapeutic agents. Cancer Chemother. Pharmacol., 52, 185-192.
44. Vilpo,J.A., Vilpo,L.M., Szymkowski,D.E., O'Donovan,A. and Word,R.D. (1995) An XPG DNA repair defect causing mutagen hypersensitivity in mouse leucemia L1210 cells. Mol. Cell. Biol., 15, 290-297.
45. Westerhof,G.R., Down,J.D., Blokland,I., Wood,M., Boudewijn,A., Watson,A.J., McGown,A.T., Ploemacher,R.E. and Margison,G.P. (2001) O6-benzylguanine potentiates BCNU but not busulfan toxicity in hematopoietic stem cells. Exp. Hematol., 29, 633-638.